Sarah J. Schlesinger

5.1k total citations · 1 hit paper
21 papers, 2.4k citations indexed

About

Sarah J. Schlesinger is a scholar working on Immunology, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah J. Schlesinger has authored 21 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Virology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah J. Schlesinger's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Sarah J. Schlesinger is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Sarah J. Schlesinger collaborates with scholars based in United States, Germany and Canada. Sarah J. Schlesinger's co-authors include Ralph M. Steinman, Christine Trumpfheller, Marina Caskey, Angela Granelli‐Piperno, Mary Marovich, Michael A. Eller, Yaoxing Huang, S Sarasombath, Timothy H. Burgess and Boonrat Tassaneetrithep and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Sarah J. Schlesinger

21 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells

2003 702 citations Boonrat Tassaneetrithep, Timothy H. Burgess et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah J. Schlesinger United States	13	1.5k	700	567	524	443	21	2.4k
Isabelle Staropoli France	21	643 0.4×	771 1.1×	466 0.8×	402 0.8×	491 1.1×	37	2.0k
Carl W. Davis United States	20	1.4k 0.9×	927 1.3×	627 1.1×	463 0.9×	174 0.4×	30	2.7k
Jeffrey R. Currier United States	26	1.0k 0.7×	590 0.8×	422 0.7×	431 0.8×	721 1.6×	87	1.9k
Simon M. Barratt‐Boyes United States	31	1.9k 1.3×	933 1.3×	700 1.2×	241 0.5×	571 1.3×	73	3.3k
Xiao‐Ning Xu United Kingdom	30	1.3k 0.9×	1.2k 1.8×	523 0.9×	846 1.6×	760 1.7×	55	3.1k
Galina V. Yamshchikov United States	25	1.8k 1.2×	735 1.1×	1.1k 1.9×	359 0.7×	366 0.8×	38	3.0k
Devon J. Shedlock United States	28	2.2k 1.5×	857 1.2×	790 1.4×	377 0.7×	463 1.0×	56	3.7k
Kesen Dang United States	22	1.6k 1.1×	535 0.8×	807 1.4×	295 0.6×	647 1.5×	27	2.4k
Marcin Kwissa United States	16	1.3k 0.9×	496 0.7×	662 1.2×	256 0.5×	137 0.3×	19	2.0k
Christine Trumpfheller United States	28	4.2k 2.8×	821 1.2×	1.4k 2.4×	623 1.2×	802 1.8×	41	5.5k

Countries citing papers authored by Sarah J. Schlesinger

Since Specialization

Citations

This map shows the geographic impact of Sarah J. Schlesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah J. Schlesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah J. Schlesinger more than expected).

Fields of papers citing papers by Sarah J. Schlesinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah J. Schlesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah J. Schlesinger. The network helps show where Sarah J. Schlesinger may publish in the future.

Co-authorship network of co-authors of Sarah J. Schlesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah J. Schlesinger. A scholar is included among the top collaborators of Sarah J. Schlesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah J. Schlesinger. Sarah J. Schlesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kost, Rhonda G., Manoj Kandpal, Robert B. MacArthur, et al.. (2023). Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experience. Journal of Clinical and Translational Science. 7(1). e104–e104. 2 indexed citations

Vaughan, Roger, Rhonda G. Kost, Bernadette Capili, et al.. (2021). The Rockefeller Team Science Leadership training program: Curriculum, standardized assessment of competencies, and impact of returning assessments. SHILAP Revista de lepidopterología. 5(1). e165–e165. 4 indexed citations

Vaughan, Roger, et al.. (2020). 4037 Assessing Leadership Skills in Translational Science Training: The Rockefeller University Leadership Survey. SHILAP Revista de lepidopterología. 4(s1). 116–117. 1 indexed citations

Schlesinger, Sarah J., Jonathan N. Tobin, Rhonda G. Kost, et al.. (2017). The Rockefeller University Clinical Scholars (KL2) program 2006–2016. Journal of Clinical and Translational Science. 1(5). 285–291. 6 indexed citations

Schoofs, Till, Florian Klein, Edward F. Kreider, et al.. (2016). HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science. 352(6288). 997–1001. 227 indexed citations

Wang, Taia T., Jad Maamary, Sarah J. Schlesinger, & Jeffrey V. Ravetch. (2015). IgG anti-HA Fc glycoform modulation is predictive of influenza vaccine efficacy (IRC10P.412). The Journal of Immunology. 194(1_Supplement). 196.10–196.10. 1 indexed citations

Maamary, Jad, Gene S. Tan, Stylianos Bournazos, et al.. (2015). Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy. Cell. 162(1). 160–169. 154 indexed citations

Anandasabapathy, Niroshana, Gaëlle Breton, Arlene Hurley, et al.. (2015). Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplantation. 50(7). 924–930. 81 indexed citations

Breton, Gaëlle, Jaeyop Lee, Yu Zhou, et al.. (2015). Circulating precursors of human CD1c+ and CD141+ dendritic cells. The Journal of Experimental Medicine. 212(3). 401–413. 148 indexed citations

10.

Anandasabapathy, Niroshana, Arlene Hurley, Gaëlle Breton, et al.. (2013). A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers. Biology of Blood and Marrow Transplantation. 19(2). S112–S113. 2 indexed citations

11.

Schlesinger, Sarah J., et al.. (2012). 64 Routine, Non-Targeted Screening for HIV: Year One Findings of the “R/O HIV in the LAC+USC ED” Program. Annals of Emergency Medicine. 60(4). S24–S25. 1 indexed citations

12.

Caskey, Marina, Christine Trumpfheller, Sarah Pollak, et al.. (2012). In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers. Retrovirology. 9(S2). 1 indexed citations

13.

Trumpfheller, Christine, M. Paula Longhi, Marina Caskey, et al.. (2011). Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity. Journal of Internal Medicine. 271(2). 183–192. 139 indexed citations

14.

Sela, Uri, Peter Olds, Andrew Park, Sarah J. Schlesinger, & Ralph M. Steinman. (2011). Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. The Journal of Experimental Medicine. 208(12). 2489–2496. 72 indexed citations

15.

Gandhi, Rajesh T., David O’Neill, Ronald J. Bosch, et al.. (2009). A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 27(43). 6088–6094. 67 indexed citations

16.

Trumpfheller, Christine, Marina Caskey, Godwin Nchinda, et al.. (2008). The microbial mimic poly IC induces durable and protective CD4⁺T cell immunity together with a dendritic cell targeted vaccine. Proceedings of the National Academy of Sciences. 105(7). 2574–2579. 245 indexed citations

17.

Nchinda, Godwin, Janelle Kuroiwa, Margarita Oks, et al.. (2008). The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. Journal of Clinical Investigation. 118(4). 1427–1436. 141 indexed citations

18.

Trumpfheller, Christine, Carolina B. López, Thomas M. Moran, et al.. (2006). Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine. The Journal of Experimental Medicine. 203(3). 607–617. 184 indexed citations

19.

Ignatius, Ralf, Michael A. Eller, Kevin A. Wilkinson, et al.. (2004). Macaque Dendritic Cells Infected with SIV-Recombinant Canarypox ex Vivo Induce SIV-Specific Immune Responses in Vivo. AIDS Research and Human Retroviruses. 20(8). 871–884. 13 indexed citations

20.

Tassaneetrithep, Boonrat, Timothy H. Burgess, Angela Granelli‐Piperno, et al.. (2003). DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells. The Journal of Experimental Medicine. 197(7). 823–829. 702 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact